Clonal analysis of erythroid progenitors suggests that pegylated interferon alpha-2a treatment targets JAK2V617F clones without affecting TET2 mutant cells.

J. J. Kiladjian,Aline Massé,Bruno Cassinat,Hayat Mokrani,Irène Teyssandier,J-P Le Couédic,Nathalie Cambier,Carole Almire,Elodie Pronier,N Casadevall,William Vainchenker,Christine Chomienne,François Delhommeau

Clonal analysis of erythroid progenitors suggests that pegylated interferon alpha-2a treatment targets JAK2V617F clones without affecting TET2 mutant cells.

2010

J. J. Kiladjian
Aline Massé
Bruno Cassinat
Hayat Mokrani
Irène Teyssandier
J-P Le Couédic
Nathalie Cambier
Carole Almire
Elodie Pronier
N Casadevall
William Vainchenker
Christine Chomienne
François Delhommeau

Clonal analysis of erythroid progenitors suggests that pegylated interferon α-2a treatment targets JAK2 V617F clones without affecting TET2 mutant cells

Keywords:

Interferon alfa
Cancer research
Alpha interferon
Genetics
Progenitor cell
Stem cell
Erythropoiesis
Mutant
Mutation
Pegylated interferon
Biology
Tumor suppressor gene
Hematology
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations